1. Adern A (1987) Characterization of muscarinic and nicotinic receptors in neural and non-neural tissue: changes in Alzheimer’s disease. Acta Universitas Uppsaliensis: Comprehensive summaries of Uppsala Dissertations from the Faculty of Pharmacy, vol 32: 4–61
2. Adolfsson R, Gottfries CG, Oreland L, Wiberg A, Winblad B (1980) Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci 27: 1029–1034
3. Allard P, Alafuzoff I, Carlsson A, Eriksson K, Ericson E, et al (1990) Loss of dopamine uptake sites labeled with (3H)GBR-12935 in Alzheimer’s disease. Eur Neurol 30: 181–185
4. Antuono P, Sorbi S, Bracco L, Fusco T, Amaducci L (1980) A discrete sampling technique in senile dementia of the Alzheimer type and alcoholic dementia: study of the cholinergic system. In: Amaducci L, et al (eds) Aging of the brain and dementia. Raven Press, New York, pp 151–158
5. Aoyagi T, Wada T, Nagai M, Kojima F, Harada S, et al (1990) Increased gammaaminobutyrate aminotransferase activity in brain of patients with Alzheimer’s disease. Chem Pharm Bull 38: 1748–1749